April W. Armstrong, MD, MPH, Professor and Chief of Dermatology, University of California, Los Angeles
home / authors / april-w-armstrong-md-mph-professor-and-chief-of-dermatology-university-of-california-los-angeles-
Articles
OX40-Ligand: A Conductor of the Atopic Dermatitis Inflammatory Symphony?
April W. Armstrong, MD, MPH, Professor and Chief of Dermatology, University of California, Los Angeles;Kassim Rahawi, PharmD, Sanofi, Cambridge, USA;Wendell Valdecantos, MD, Sanofi, Cambridge, USA;Stella Kyaw-Soe, PharmD, MBA, Sanofi, Cambridge, USA
October 22nd 2024Given the complexity of the underlying inflammation in patients with AD, an increased understanding of the OX40L pathway can improve our understanding of AD pathogenesis.
Latest Updated Articles
Published: September 19th 2024 | Updated: September 26th 2024
Final Thoughts: The Importance of Comparative Studies in AD
Published: June 6th 2023 | Updated: May 5th 2025
POLL: What Percentage of the Population Has Hidradenitis Suppurativa?
Published: April 29th 2025 | Updated: May 5th 2025
FDA Approves First Gene Therapy for RDEB
Published: April 18th 2025 | Updated: May 5th 2025
FDA Approves Dupilumab for Adolescents and Adults With H1 Antihistamine-Refractory Chronic Spontaneous Urticaria
Published: April 22nd 2025 | Updated: May 5th 2025
Using Real-World AD Cases to Pick the Right Therapy for Each Patient
Published: April 1st 2025 | Updated: May 5th 2025
Optimizing Vitiligo Care: Key Expert Takeaways
